Eywa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EYWA, and what generic and branded alternatives to EYWA drugs are available?
EYWA has twelve approved drugs.
Drugs and US Patents for Eywa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eywa | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 214426-003 | Feb 19, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eywa | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 213090-001 | Aug 25, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eywa | ALBUTEROL SULFATE | albuterol sulfate | TABLET;ORAL | 213524-001 | Oct 8, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Eywa | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 207863-003 | Feb 4, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eywa | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 214426-002 | Feb 19, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eywa Pharma | BACLOFEN | baclofen | TABLET;ORAL | 211555-003 | Nov 30, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eywa | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 213090-002 | Aug 25, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.